The store will not work correctly when cookies are disabled.
N-3-(1H-Tetrazol-5-yl)phenyl]biphenyl-3-sulfonamide
ID: ALA3729559
PubChem CID: 56943089
Max Phase: Preclinical
Molecular Formula: C19H15N5O2S
Molecular Weight: 377.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=S(=O)(Nc1cccc(-c2nnn[nH]2)c1)c1cccc(-c2ccccc2)c1
Standard InChI: InChI=1S/C19H15N5O2S/c25-27(26,18-11-5-8-15(13-18)14-6-2-1-3-7-14)22-17-10-4-9-16(12-17)19-20-23-24-21-19/h1-13,22H,(H,20,21,23,24)
Standard InChI Key: FRGRLULPHNFQGA-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
1.5548 -3.6021 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.5568 -2.4023 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5987 -1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9511 -0.8815 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9530 -1.9978 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.2010 -3.2957 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.7343 -2.9815 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8902 -5.2570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1877 -6.0097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4883 -5.2623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4914 -3.7623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1939 -3.0097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7926 -3.0146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0914 -3.7652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3908 -3.0158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3915 -1.5158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0928 -0.7652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7934 -1.5146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 2 0
2 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
9 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 11 1 0
2 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
20 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 377.43 | Molecular Weight (Monoisotopic): 377.0946 | AlogP: 3.33 | #Rotatable Bonds: 5 |
Polar Surface Area: 100.63 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.28 | CX Basic pKa: ┄ | CX LogP: 3.39 | CX LogD: 1.64 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.56 | Np Likeness Score: -1.95 |
References
1. (2012) New compounds, |
2. (2016) Sulfonamide compounds, |